Cytrellis Biosystems, Inc.

Cytrellis, a venture-backed medical technology company, is developing a new, proprietary category of micro-coring devices designed to remove sagging skin associated with aging, without surgery or scarring. The devices have the potential to provide aesthetic practitioners with an unprecedented ability to improve age related changes in skin and restore youthful beauty. Cytrellis is dedicated to working with leading physicians to develop unique product solutions which emphasize safety, clinical results and improved quality of life. The Cytrellis device is an investigational product limited by federal law to investigational use. The Cytrellis device has not been cleared for marketing by the U.S. Food and Drug Administration.